086900 fundamentals
MEDY-TOX INC. revenue breakdown overview
MEDY-TOX INC. revenue for the last year amounted to 221.06 B KRW, the most of which — 217.16 B KRW — came from its highest performing source at the moment, Biopharmaceutical Products, the year earlier bringing 191.46 B KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought MEDY-TOX INC. 79.82 B KRW, and the year before that — 66.70 B KRW.
By source
2016
2017
2018
2019
2020
2021
2022
2023
0.00
60.00 B
120.00 B
180.00 B
240.00 B
Biopharmaceutical Products
Biopharmaceutical Products - Products
Rental
Biopharmaceutical Products - Merchandise
Other
Currency: KRW
2016
2017
2018
2019
2020
2021
2022
2023
Biopharmaceutical Products
205.90 B
140.83 B
184.87 B
191.46 B
217.16 B
Biopharmaceutical Products - Products
—
—
—
—
—
Rental
—
—
—
—
—
Biopharmaceutical Products - Merchandise
—
—
—
—
—
Other
—
—
—
—
—
By country
2016
2017
2018
2019
2020
2021
2022
2023
0.00
60.00 B
120.00 B
180.00 B
240.00 B
South Korea
Asia
America
Middle East
Europe
Other
Africa
Oceania
Currency: KRW
2016
2017
2018
2019
2020
2021
2022
2023
South Korea
78.52 B
44.26 B
62.51 B
66.70 B
79.82 B
Asia
92.18 B
69.45 B
49.78 B
69.18 B
73.71 B
America
24.66 B
20.25 B
64.52 B
43.63 B
48.30 B
Middle East
5.41 B
4.19 B
3.71 B
4.93 B
8.54 B
Europe
4.60 B
2.31 B
4.00 B
6.55 B
6.56 B
Other
—
—
—
—
226.72 M
Africa
386.46 M
222.74 M
207.54 M
268.02 M
—
Oceania
149.60 M
132.60 M
132.84 M
197.94 M
—